Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Human Microbiome Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Human Microbiome Therapeuticsmarket, defines the market attractiveness level of Human Microbiome Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Human Microbiome Therapeutics industry, describes the types of Human Microbiome Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Microbiome Therapeutics market and the development prospects and opportunities of Human Microbiome Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Microbiome Therapeutics market in Chapter 13.
By Player:
Vedanta Biosciences
Seres Therapeutics
ENTEROME Bioscience
Rebiotix
Johnson & Johnson
Takeda Pharmaceutical
Bristol-Myers Squibb
By Type:
Upper GIT
Lower GIT
By End-User:
Intestines And Stomach
Oral
Respiratory Tract
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Human Microbiome Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Human Microbiome Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Human Microbiome Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Human Microbiome Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Human Microbiome Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Human Microbiome Therapeutics Consumption (2017-2022)
-
7.2 United States Human Microbiome Therapeutics Consumption (2017-2022)
-
7.3 Europe Human Microbiome Therapeutics Consumption (2017-2022)
-
7.4 China Human Microbiome Therapeutics Consumption (2017-2022)
-
7.5 Japan Human Microbiome Therapeutics Consumption (2017-2022)
-
7.6 India Human Microbiome Therapeutics Consumption (2017-2022)
-
7.7 South Korea Human Microbiome Therapeutics Consumption (2017-2022)
8 Region and Country-wise Human Microbiome Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Human Microbiome Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Human Microbiome Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Human Microbiome Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Human Microbiome Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Human Microbiome Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Human Microbiome Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Human Microbiome Therapeutics Consumption Forecast (2022-2028)
9 Global Human Microbiome Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Human Microbiome Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Upper GIT Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lower GIT Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Microbiome Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Intestines And Stomach Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oral Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Respiratory Tract Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Human Microbiome Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Human Microbiome Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Upper GIT Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Lower GIT Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Human Microbiome Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Intestines And Stomach Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Respiratory Tract Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Human Microbiome Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Human Microbiome Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Human Microbiome Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Human Microbiome Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Human Microbiome Therapeutics Market Competitive Analysis
-
14.1 Vedanta Biosciences
-
14.1.1 Vedanta Biosciences Company Details
-
14.1.2 Vedanta Biosciences Human Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Vedanta Biosciences Human Microbiome Therapeutics Product and Service
-
14.2 Seres Therapeutics
-
14.2.1 Seres Therapeutics Company Details
-
14.2.2 Seres Therapeutics Human Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Seres Therapeutics Human Microbiome Therapeutics Product and Service
-
14.3 ENTEROME Bioscience
-
14.3.1 ENTEROME Bioscience Company Details
-
14.3.2 ENTEROME Bioscience Human Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 ENTEROME Bioscience Human Microbiome Therapeutics Product and Service
-
14.4 Rebiotix
-
14.4.1 Rebiotix Company Details
-
14.4.2 Rebiotix Human Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Rebiotix Human Microbiome Therapeutics Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Human Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Human Microbiome Therapeutics Product and Service
-
14.6 Takeda Pharmaceutical
-
14.6.1 Takeda Pharmaceutical Company Details
-
14.6.2 Takeda Pharmaceutical Human Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Takeda Pharmaceutical Human Microbiome Therapeutics Product and Service
-
14.7 Bristol-Myers Squibb
-
14.7.1 Bristol-Myers Squibb Company Details
-
14.7.2 Bristol-Myers Squibb Human Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Human Microbiome Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Human Microbiome Therapeutics
-
Figure Human Microbiome Therapeutics Picture
-
Table Global Human Microbiome Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Microbiome Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Microbiome Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Human Microbiome Therapeutics Consumption by Country (2017-2022)
-
Figure United States Human Microbiome Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Human Microbiome Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Human Microbiome Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Microbiome Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Human Microbiome Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Microbiome Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Human Microbiome Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Human Microbiome Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Microbiome Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Human Microbiome Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Microbiome Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Microbiome Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Microbiome Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Upper GIT Consumption and Growth Rate (2017-2022)
-
Figure Global Lower GIT Consumption and Growth Rate (2017-2022)
-
Figure Global Intestines And Stomach Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Tract Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Upper GIT Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lower GIT Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intestines And Stomach Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory Tract Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Human Microbiome Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Human Microbiome Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Vedanta Biosciences (Foundation Year, Company Profile and etc.)
-
Table Vedanta Biosciences Human Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vedanta Biosciences Human Microbiome Therapeutics Product and Service
-
Table Seres Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Seres Therapeutics Human Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seres Therapeutics Human Microbiome Therapeutics Product and Service
-
Table ENTEROME Bioscience (Foundation Year, Company Profile and etc.)
-
Table ENTEROME Bioscience Human Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table ENTEROME Bioscience Human Microbiome Therapeutics Product and Service
-
Table Rebiotix (Foundation Year, Company Profile and etc.)
-
Table Rebiotix Human Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rebiotix Human Microbiome Therapeutics Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Human Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Human Microbiome Therapeutics Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Human Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Human Microbiome Therapeutics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Human Microbiome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Human Microbiome Therapeutics Product and Service
-
